8NN fundamentals
An in-depth look to THOR MEDICAL ASA operating, investing, and financing activities
8NN free cash flow for H2 23 is -1.17 M EUR. For 2023, 8NN free cash flow was -5.52 M EUR and operating cash flow was -5.52 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM